World Health Organization Cardiovascular diseases (CVDs) Fact Sheet. 2021. [(accessed on 1 Desember 2021)]. Available online: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
World Health Organization Cardiovascular diseases (CVDs) Fact Sheet. 2021. [(accessed on 1 Desember 2021)]. Available online: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
Федеральная служба государственной статистики: [Электронный ресурс] . URL: https://rosstat.gov.ru/folder/13721https://rosstat.gov.ru/folder/13721
Федеральная служба государственной статистики: [Электронный ресурс] . URL: https://rosstat.gov.ru/folder/13721https://rosstat.gov.ru/folder/13721
Pahwa R., Jialal I. Atherosclerosis. Treasure Island (FL): StatPearls Publishing [Internet], 2022. URL: https://www.ncbi.nlm.nih.gov/books/NBK507799/https://www.ncbi.nlm.nih.gov/books/NBK507799/
Pahwa R., Jialal I. Atherosclerosis. Treasure Island (FL): StatPearls Publishing [Internet], 2022. URL: https://www.ncbi.nlm.nih.gov/books/NBK507799/https://www.ncbi.nlm.nih.gov/books/NBK507799/
Atlas Writing Group; Timmis A., Townsend N., Gale C.P., Torbica A., Lettino M., Petersen S.E., Mossialos E.A., et al. European Society of Cardiology: Cardiovascular Disease Statistics 2019 (Executive Summary). Eur Heart J Qual Care Clin Outcomes. 2020;6(1):7-9. DOI: 10.1093/ehjqcco/qcz065..
DOI: 10.1093/ehjqcco/qcz065
Altena R., Hubbert L., Kiani N.A., Wengström Y., Bergh J., Hedayati E. Evidence-based prediction and prevention of cardiovascular morbidity in adults treated for cancer. Cardio-Oncology. 2021;7(1):20. DOI: 10.1186/s40959-021-00105-y..
DOI: 10.1186/s40959-021-00105-y
International agency for research on cancer: cancer tomorrow [electronic resource] URL: https://gco.iarc.fr/tomorrow/en/dataviz/isotypehttps://gco.iarc.fr/tomorrow/en/dataviz/isotype
International agency for research on cancer: cancer tomorrow [electronic resource] URL: https://gco.iarc.fr/tomorrow/en/dataviz/isotypehttps://gco.iarc.fr/tomorrow/en/dataviz/isotype
Rubens-Figueroa J., Cárdenas-Cardós R. Importance of cardio-oncology. How to detect suclinical heart failure. Arch Cardiol Mex. 2021;91(2):229-234. DOI: 10.24875/ACM.19000394..
DOI: 10.24875/ACM.19000394
Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33. DOI: 10.3322/caac.21654..
DOI: 10.3322/caac.21654
Shapiro C.L. Cancer Survivorship. N Engl J Med. 2018;379(25):2438-2450. DOI: 10.1056/NEJMra1712502..
DOI: 10.1056/NEJMra1712502
Мещерина Н.С., Михайленко Т.С., Хардикова Е.М., Сараев И.А., Леонтьева Т.С. Кардиоваскулярная токсичность, индуцированная химиотерапией и таргетными препаратами: механизмы развития, подходы к диагностике и профилактике. Человек и его здоровье. 2021;24(4):24-33. DOI: 10.21626/vestnik/2021-4/04. EDN: SYUPKS..
DOI: 10.21626/vestnik/2021-4/04. EDN: SYUPKS
Liu Y., Tan D., Shi L., Liu X., Zhang Y., Tong C., Song D., Hou M. Blueberry anthocyanins enriched extracts attenuate cyclophosphamide-induced cardiac injury. PLoS One. 2015;10(7):e0127813. DOI: 10.1371/journal.pone.0127813..
DOI: 10.1371/journal.pone.0127813
Dent S., Liu P., Brezden-Masley C., Lenihan D. Cancer and Cardiovascular Disease: The Complex Labyrinth. J Oncol. 2015;2015:516450. DOI: 10.1155/2015/516450..
DOI: 10.1155/2015/516450
Anker M.S., Von Haehling S., Landmesser U., Coats A.J., Anker S.D. Cancer and heart failure-more than meets the eye: Common risk factors and co-morbidities. Eur J Heart Fail. 2018;20(10):1382-1384. DOI: 10.1002/ejhf.1252..
DOI: 10.1002/ejhf.1252
Hamo C.E., Bloom M.W., Cardinale D., Ky B., Nohria A., Baer L., Skopicki H., Lenihan D.J., et al. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions. Circ Heart Fail. 2016;9(2):e002843. DOI: 10.1161/CIRCHEARTFAILURE.115.002843..
DOI: 10.1161/CIRCHEARTFAILURE.115.002843
Мещерина Н.С., Степченко М.А., Леонтьева Т.С., Хардикова Е.М., Михайленко Т.С. Подходы к ранней диагностике и профилактике кардиоваскулярной токсичности, индуцированной таргетными препаратами и ингибиторами контрольных точек иммунитета, в онкогематологии (обзор литературы). Кардиоваскулярная терапия и профилактика. 2023;22(1):3337. DOI: 10.15829/1728-8800-2023-3337. EDN: NFLIGQ..
DOI: 10.15829/1728-8800-2023-3337. EDN: NFLIGQ
Vincent L., Leedy D., Masri S.C., Cheng R.K. Cardiovascular disease and Cancer: is there increasing overlap? Curr Oncol Rep. 2019;21(6):47. DOI: 10.1007/s11912-019-0796-0..
DOI: 10.1007/s11912-019-0796-0
Rafati S., Baneshi M.R., Bahrampour A. Factors Affecting Long-Survival of Patients with Breast Cancer by Non-Mixture and Mixture Cure Models Using the Weibull, Log-logistic and Dagum Distributions: A Bayesian Approach. Asian Pac J Cancer Prev. 2020;21(2):485-490. DOI: 10.31557/APJCP.2020.21.2.485..
DOI: 10.31557/APJCP.2020.21.2.485
Zaha V.G., Hayek S.S., Alexander K.M., Beckie T.M., Hundley W.G., Kondapalli L., Ky B., Leger K.J., et al. Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association. Circulation. 2021;144(25):e551-e563. DOI: 10.1161/CIR.0000000000001032..
DOI: 10.1161/CIR.0000000000001032
Hoeger C.W., Hayek S.S. Role of Cardiovascular Biomarkers in the Risk Stratification, Monitoring, and Management of Patients with Cancer. Cardiol Clin. 2019;37(4):505-523. DOI: 10.1016/j.ccl.2019.07.015..
DOI: 10.1016/j.ccl.2019.07.015
Чазова И.Е., Агеев Ф.Т., Аксенова А.В., Виценя М.В., Гиляров М.Ю., Мартынюк Т.В., Панченко Е.П., Полтавская М.Г., и др. Евразийские клинические рекомендации по диагностике, профилактике и лечению сердечно-сосудистых осложнений при противоопухолевой терапии (2022). Евразийский кардиологический журнал. 2022;(1): 6-79. DOI: 10.38109/2225-1685-2022-1-6-79. EDN: SIVDQT..
DOI: 10.38109/2225-1685-2022-1-6-79. EDN: SIVDQT
Lyon A.R., López-Fernández T., Couch L.S., Asteggiano R., Aznar M.C., Bergler-Klein J., Boriani G., Cardinale D., et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(41):4229-4361. DOI: 10.1093/eurheartj/ehac244..
DOI: 10.1093/eurheartj/ehac244
Armenian S.H., Lacchetti C., Lenihan D. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline Summary. J Oncol Pract. 2017;13(4):270-275. DOI: 10.1200/JOP.2016.018770..
DOI: 10.1200/JOP.2016.018770
Кириченко Ю.Ю., Ильгисонис И.С., Иванова Т.В., Золотухина А.С., Хабарова Н.В., Привалова Е.В., Беленков Ю.Н. Кардиоваскулотоксические проявления противоопухолевой терапии: влияние на ремоделирование миокарда и сосудистого русла. Кардиоваскулярная терапия и профилактика. 2021;20(7):2923. DOI: 10.15829/1728-8800-2021-2923. EDN: HDSBXX..
DOI: 10.15829/1728-8800-2021-2923. EDN: HDSBXX
Plana J.C., Galderisi M., Barac A., Ewer M.S., Ky B., Scherrer-Crosbie M., Ganame J., Sebag I.A., et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15(10):1063-1093. DOI: 10.1093/ehjci/jeu192..
DOI: 10.1093/ehjci/jeu192
Кузьмина Т.П., Давыдкин И.Л., Терешина О.В., Данилова О.Е., Шпигель А.С., Бетанели Т.Ш., Наумова К.В., Попельнюк Н.С. Кардиотоксичность и методы ее диагностики у пациентов гематологического профиля (обзор литературы). Сибирский научный медицинский журнал. 2019;39(1):34-42. DOI: 10.15372/SSMJ20190105. EDN: YZAKFN..
DOI: 10.15372/SSMJ20190105. EDN: YZAKFN
Posch F., Niedrist T., Glantschnig T., Firla S., Moik F., Kolesnik E., Wallner M., Verheyen N., et al. Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer. Front Cardiovasc Med. 2022;9:933428. DOI: 10.3389/fcvm.2022.933428..
DOI: 10.3389/fcvm.2022.933428
Čelutkienė J., Plymen C.M., Flachskampf F.A., de Boer R.A., Grapsa J., Manka R., Anderson L., Garbi M., et al. Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(12):1615-1633. DOI: 10.1002/ejhf.1330..
DOI: 10.1002/ejhf.1330
Awadalla M., Hassan M.Z.O., Alvi R.M., Neilan T.G. Advanced imaging modalities to detect cardiotoxicity. Curr Probl Cancer. 2018;42(4):386-396. DOI: 10.1016/j.currproblcancer.2018.05.005..
DOI: 10.1016/j.currproblcancer.2018.05.005
Di Lisi D., Manno G., Novo G. Subclinical Cardiotoxicity: The Emerging Role of Myocardial Work and Other Imaging Techniques. Curr Probl Cardiol. 2021;46(6):100818. DOI: 10.1016/j.cpcardiol.2021.100818..
DOI: 10.1016/j.cpcardiol.2021.100818
Thavendiranathan P., Grant A.D., Negishi T., Plana J.C., Popovic Z.B., Marwick T.H. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013;61:77-84. DOI: 10.1016/j.jacc.2012.09.035..
DOI: 10.1016/j.jacc.2012.09.035
Toro-Salazar O.H., Ferranti J., Lorenzoni R., Walling S., Mazur W., Raman S.V., Davey B.T., Gillan E., et al. Feasibility of echocardiographic techniques to detect subclinical cancer therapeutics-related cardiac dysfunction among high-dose patients when compared with cardiac magnetic resonance imaging. J Am Soc Echocardiogr. 2016;29(2):119-131. DOI: 10.1016/j.echo.2015.10.008..
DOI: 10.1016/j.echo.2015.10.008
Саидова М.А., Авалян А.А., Ощепкова Е.В., Шитов В.Н., Чазова И.Е. Сравнительные возможности метода спекл-трекинг-эхокардиографии в двумерном и трехмерном режимах в выявлении субклинической кардиотоксичности у больных раком молочной железы. Терапевтический архив. 2020;92(12):142-147. DOI: 10.26442/00403660.2020.12.200431. EDN: XGQQKU..
DOI: 10.26442/00403660.2020.12.200431. EDN: XGQQKU
Corrigendum to ‘Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)’ [Eur J Heart Fail 2020;22:1504-1524]. Eur J Heart Fail. 2021;23(2):345. DOI: 10.1002/ejhf.2153..
DOI: 10.1002/ejhf.2153
Никифоров В.С., Никищенкова Ю.В. Cовременные возможности speckle tracking эхокардиографии в клинической практике. Рациональная Фармакотерапия в Кардиологии. 2017;13(2):248-255. DOI: 10.20996/1819-6446-2017-13-2-248-255. EDN: YOCTIR..
DOI: 10.20996/1819-6446-2017-13-2-248-255. EDN: YOCTIR
Baron T., Berglund L., Hedin E.M., Flachskampf F.A. Test-retest reliability of new and conventional echocardiographic parameters of left ventricular systolic function. Clin Res Cardiol. 2019;108(4):355-365. DOI: 10.1007/s00392-018-1363-7..
DOI: 10.1007/s00392-018-1363-7
Авалян А.А., Саидова М.А., Ощепкова Е.В., Чазова И.Е. Современные подходы к выявлению ранней субклинической кардиотоксичности, индуцированной химиотерапией, у больных раком молочной железы. Евразийский Кардиологический Журнал. 2018;(3):50-61. EDN: XYZPKX.
Gripp E.A., Oliveira G.E., Feijó L.A., Garcia M.I., Xavier S.S., Sousa A.S. Global longitudinal strain accuracy for cardiotoxicity prediction in a cohort of breast cancer patients during anthracycline and/or trastuzumab treatment. Arq Bras Cardiol. 2018;110(2):140-150. DOI: 10.5935/abc.20180021..
DOI: 10.5935/abc.20180021
Guerra F., Marchesini M., Contadini D., Menditto A., Morelli M., Piccolo E., Battelli N., Pistelli M., et al. Speckle-tracking global longitudinal strain as an early predictor of cardiotoxicity in breast carcinoma. Support Care Cancer. 2016;24(7):3139-3145. DOI: 10.1007/s00520-016-3137-y..
DOI: 10.1007/s00520-016-3137-y
Paraskevaidis I.A., Makavos G., Tsirigotis P., Psarogiannakopoulos P., Parissis J., Gkirkas K., Pessach I., Ikonomidis I. Deformation analysis of myocardial layers detects early cardiac dysfunction after chemotherapy in bone marrow transplantation patients: a continuous and additive cardiotoxicity process. J Am Soc Echocardiogr. 2017;30(11):1091-1102. DOI: 10.1016/j.echo.2017.07.010..
DOI: 10.1016/j.echo.2017.07.010
Oikonomou E.K., Kokkinidis D.G., Kampaktsis P.N., Amir E.A., Marwick T.H., Gupta D., Thavendiranathan P. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis. JAMA Cardiol. 2019;4(10):1007-1018. DOI: 10.1001/jamacardio.2019.2952..
DOI: 10.1001/jamacardio.2019.2952
Ali M.T., Yucel E., Bouras S., Wang L., Fei H.W., Halpern E.F., Scherrer-Crosbie M. Myocardial Strain Is Associated with Adverse Clinical Cardiac Events in Patients Treated with Anthracyclines. J Am Soc Echocardiogr. 2016;29(6):522-527.e3. DOI: 10.1016/j.echo.2016.02.018..
DOI: 10.1016/j.echo.2016.02.018
Milks M.W., Velez M.R., Mehta N., Ishola A., Van Houten T., Yildiz V.O., Reinbolt R., Lustberg M., et al. Usefulness of integrating heart failure risk factors into impairment of global longitudinal strain to predict anthracycline-related cardiac dysfunction. Am J Cardiol. 2018;121(7):867-873. DOI: 10.1016/j.amjcard.2017.12.022..
DOI: 10.1016/j.amjcard.2017.12.022
Liu J.E., Barac A., Thavendiranathan P., Scherrer-Crosbie M. Strain Imaging in Cardio-Oncology. JACC CardioOncol. 2020;2(5):677-689. DOI: 10.1016/j.jaccao.2020.10.011..
DOI: 10.1016/j.jaccao.2020.10.011
Fei H.W., Ali M.T., Tan T.C., Cheng K.H., Salama L., Hua L., Zeng X., Halpern E.F., et al. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction. Echocardiography. 2016;33(4): 519-526. DOI: 10.1111/echo.13168..
DOI: 10.1111/echo.13168
Tadic M., Baudisch A., Haßfeld S., Heinzel F., Cuspidi C., Burkhardt F., Escher F., Attanasio P., et al. Right ventricular function and mechanics in chemotherapy- and radiotherapy-naïve cancer patients.Int J Cardiovasc Imaging. 2018;34(10):1581-1587. DOI: 10.1007/s10554-018-1379-0..
DOI: 10.1007/s10554-018-1379-0
Chang W.T., Shih J.Y., Feng Y.H., Chiang C.Y., Kuo Y.H., Chen W.Y., Wu H.C., Cheng J.T., et al. The early predictive value of right ventricular strain in epirubicin-induced cardiotoxicity in patients with breast cancer. Acta Cardiol Sin. 2016;32(5):550-559. DOI: 10.6515/acs20151023a..
DOI: 10.6515/acs20151023a
Florescu M., Magda L.S., Enescu O.A., Jinga D., Vinereanu D. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer. J Am Soc Echocardiogr. 2014;27(1):83-92. DOI: 10.1016/j.echo.2013.10.008..
DOI: 10.1016/j.echo.2013.10.008
Thavendiranathan P., Negishi T., Somerset E., Negishi K., Penicka M., Lemieux J., Aakhus S., Miyazaki S., et al. Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy. J Am Coll Cardiol. 2021;77(4):392-401. DOI: 10.1016/j.jacc.2020.11.020..
DOI: 10.1016/j.jacc.2020.11.020
Negishi T., Thavendiranathan P., Penicka M., Lemieux J., Murbraech K., Miyazaki S., Shirazi M., Santoro C., et al. Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial. JACC Cardiovasc Imaging. 2023;16(3):269-278. DOI: 10.1016/j.jcmg.2022.10.010..
DOI: 10.1016/j.jcmg.2022.10.010
Papadopoulos K., Özden Tok Ö., Mitrousi K., Ikonomidis I. Myocardial Work: Methodology and Clinical Applications. Diagnostics (Basel). 2021;11(3):573. DOI: 10.3390/diagnostics11030573..
DOI: 10.3390/diagnostics11030573
Boe E., Russell K., Eek C., Eriksen M., Remme E.W., Smiseth O.A., Skulstad H. Non-invasive myocardial work index identifies acute coronary occlusion in patients with non-ST-segment elevation-acute coronary syndrome. Eur Heart J Cardiovasc Imaging. 2015;16(11):1247-1255. DOI: 10.1093/ehjci/jev078..
DOI: 10.1093/ehjci/jev078
Kosmala W., Negishi T., Thavendiranathan P., Penicka M., De Blois J., Murbræch K., Miyazaki S., Shirazi M., et al. Incremental Value of Myocardial Work over Global Longitudinal Strain in the Surveillance for Cancer-Treatment-Related Cardiac Dysfunction: A Case-Control Study. J Clin Med. 2022;11(4):912. DOI: 10.3390/jcm11040912..
DOI: 10.3390/jcm11040912
Zhang L., Zhang R., Shuai P., Chen J., Yin L. A global case meta-analysis of three-dimensional speckle tracking for evaluating the cardiotoxicity of anthracycline chemotherapy in breast cancer. Front Cardiovasc Med. 2022;9:942620. DOI: 10.3389/fcvm.2022.942620..
DOI: 10.3389/fcvm.2022.942620
Zhai Z., Qin W., Wang Z., Dong S., Guo X., Zhang C., Wang Z., Lu G., Huang L. Changes in left ventricular function induced by carboplatin combined with paclitaxel in patients with ovarian cancer identified using three-dimensional spot tracking imaging technology. J Clin Ultrasound. 2021;49(4):378-384. DOI: 10.1002/jcu.22941..
DOI: 10.1002/jcu.22941
Wang Z., Qin W., Zhai Z., Huang L., Feng J., Guo X., Liu K., Zhang C., et al. Use of spectral tracking technique to evaluate the changes in left ventricular function in patients undergoing chemotherapy for colorectal cancer.Int J Cardiovasc Imaging. 2021;37(4):1203-1213. DOI: 10.1007/s10554-020-02103-0..
DOI: 10.1007/s10554-020-02103-0
Alam S., Chandra S., Saran M., Chaudhary G., Sharma A., Bhandhari M., Vishwakarma P., Pradhan A., et al. To study the usefulness and comparison of myocardial strain imaging by 2D and 3D echocardiography for early detection of cardiotoxicity in patients undergoing cardiotoxic chemotherapy. Indian Heart J. 2019;71(6):468-475. DOI: 10.1016/j.ihj.2019.11.253..
DOI: 10.1016/j.ihj.2019.11.253
Alam S., Chandra S., Saran M., Chaudhary G., Sharma A., Bhandhari M., Vishwakarma P., Pradhan A., et al. To study the usefulness and comparison of myocardial strain imaging by 2D and 3D echocardiography for early detection of cardiotoxicity in patients undergoing cardiotoxic chemotherapy. Indian Heart J. 2019;71(6):468-475. DOI: 10.1016/j.ihj.2019.11.253..
DOI: 10.1016/j.ihj.2019.11.253
Coutinho Cruz M., Moura Branco L., Portugal G., Galrinho A., Timóteo A.T., Rio P., Ilhão Moreira R., Mendonça T., et al. Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines. Clin Res Cardiol. 2020;109(6):673-684. DOI: 10.1007/s00392-019-01556-1..
DOI: 10.1007/s00392-019-01556-1
Song F., Kang Y., Zhang C., Xu Y., Shi J., Guo Y., Zhang Q., Shu X., et al. The early variation of left ventricular twisting function in patients with lymphoma received anthracycline therapy assessed by three-dimensional speckle tracking echocardiography. Cardiol J. 2017;24(5):484-494. DOI: 10.5603/CJ.a2017.0035..
DOI: 10.5603/CJ.a2017.0035
Jeong D., Gladish G., Chitiboi T., Fradley M.G., Gage K.L., Schiebler M.L. MRI in cardio-oncology: A review of cardiac complications in oncologic care. J Magn Reson Imaging. 2019;50(5):1349-1366. DOI: 10.1002/jmri.26895..
DOI: 10.1002/jmri.26895
Saunderson C.E.D., Plein S., Manisty C.H. Role of cardiovascular magnetic resonance imaging in cardio-oncology. Eur Heart J Cardiovasc Imaging. 2021;22(4):383-396. DOI: 10.1093/ehjci/jeaa345..
DOI: 10.1093/ehjci/jeaa345
Zhang L., Awadalla M., Mahmood S.S., Nohria A., Hassan M.Z.O., Thuny F., Zlotoff D.A., Murphy S.P., et al. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. Eur Heart J. 2020;41(18):1733-1743. DOI: 10.1093/eurheartj/ehaa051..
DOI: 10.1093/eurheartj/ehaa051
Faron A., Isaak A., Mesropyan N., Reinert M., Schwab K., Sirokay J., Sprinkart A.M., Bauernfeind F.G., et al. Cardiac MRI Depicts Immune Checkpoint Inhibitor-induced Myocarditis: A Prospective Study. Radiology. 2021;301(3):602-609. DOI: 10.1148/radiol.2021210814..
DOI: 10.1148/radiol.2021210814
Liu J., Cao Y., Zhu K., Yao S., Yuan M., Kong X., Liu X., Li Y., et al. Early evaluation of subclinical cardiotoxicity in patients with lung cancer receiving immune checkpoint inhibitors by cardiovascular magnetic resonance: a prospective observational study. Quant Imaging Med Surg. 2022;12(10): 4771-4785. DOI: 10.21037/qims-22-41..
DOI: 10.21037/qims-22-41
Lambert J., Lamacie M., Thampinathan B., Altaha M.A., Esmaeilzadeh M., Nolan M., Fresno C.U., Somerset E., et al. Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity. Heart. 2020;106(11):817-823. DOI: 10.1136/heartjnl-2019-316297..
DOI: 10.1136/heartjnl-2019-316297
Houbois C.P., Nolan M., Somerset E., Shalmon T., Esmaeilzadeh M., Lamacie M.M., Amir E., Brezden-Masley C., et al. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography. JACC Cardiovasc Imaging. 2021;14(5): 962-974. DOI: 10.1016/j.jcmg.2020.09.039.
DOI: 10.1016/j.jcmg.2020.09.039
Minotti G., Menna P., Camilli M., Salvatorelli E., Reggiardo G. Predictors of Early or Delayed Diastolic Dysfunction After Anthracycline-Based or Nonanthracycline Chemotherapy: A Pharmacological Appraisal. J Pharmacol Exp Ther. 2021;376(2):231-239. DOI: 10.1124/jpet.120.000323..
DOI: 10.1124/jpet.120.000323
Upshaw J.N., Finkelman B., Hubbard R.A., Smith A.M., Narayan H.K., Arndt L., Domchek S., DeMichele A., et al.Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy. JACC Cardiovasc Imaging. 2020;13(1 Pt 2):198-210. DOI: 10.1016/j.jcmg.2019.07.018..
DOI: 10.1016/j.jcmg.2019.07.018
Lange S.A., Jung J., Jaeck A., Hitschold T., Ebner B. Subclinical Myocardial Impairment Occurred in Septal and Anterior LV Wall Segments After Anthracycline-Embedded Chemotherapy and did not Worsen During Adjuvant Trastuzumab Treatment in Breast Cancer Patients. Cardiovasc Toxicol. 2016;16(2): 193-206. DOI: 10.1007/s12012-015-9328-9..
DOI: 10.1007/s12012-015-9328-9